CoChat

661W is a retinal ganglion precursor-like cell line in which glaucoma-associated optineurin mutants induce cell death selectively

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

A photoreceptor cell line, 661W, derived from a mouse retinal tumor that expresses several markers of cone photoreceptor cells has been described earlier. However, these cells can be differentiated into neuronal cells. Here, we report that this cell line expressed certain markers specific to retinal ganglion cells such as Rbpms, Brn3b (Pou4f2), Brn3c (Pou4f3), Thy1 and γ-synuclein (Sncg), and some other markers of neuronal cells (beta-III tubulin, NeuN and MAP2). These cells also expressed Opn1mw, a cone-specific marker and nestin, a marker for neural precursor cells. Two glaucoma-associated mutants of OPTN, E50K and M98K, but not an amyotrophic lateral sclerosis-associated mutant, E478G, induced cell death selectively in 661W cells. However, in a motor neuron cell line, NSC34, E478G mutant of OPTN but not E50K and M98K induced cell death. We conclude that 661W is a retinal ganglion precursor-like cell line, which shows properties of both retinal ganglion and photoreceptor cells. We suggest that these cells could be utilized for exploring the mechanisms of cell death induction and cytoprotection relevant for glaucoma pathogenesis. RGC-5 cell line which probably arose from 661W cells showed expression of essentially the same markers of retinal ganglion cells and neuronal cells as seen in 661W cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-17241-0

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Expression of RGC-specific markers in 661W cells. 661W and RGC-5 cell lysates were subjected to western blotting for the expression of RBPMS (A), Brn3b (B), Brn3c (C) and Thy-1 (C,D and E). For Thy1 three different antibodies sourced from CST (C), R & D systems (D) and Santa Cruz (E) were used. Mouse retina and brain were used as positive controls. Immunofluorescence staining of 661W and RGC-5 cells for Brn3b (F), Brn3c (G) and γ Synuclein (H) is shown. Staining of nuclear DNA with DAPI is shown in blue. Blank indicates negative control where cells were processed similarly without addition of primary antibody. Panels show images captured using a fluorescence microscope at 40X magnification. Scale bar, 10 µm.
Figure 1 Expression of RGC-specific markers in 661W cells. 661W and RGC-5 cell lysates were subjected to western blotting for the expression of RBPMS (A), Brn3b (B), Brn3c (C) and Thy-1 (C,D and E). For Thy1 three different antibodies sourced from CST (C), R & D systems (D) and Santa Cruz (E) were used. Mouse retina and brain were used as positive controls. Immunofluorescence staining of 661W and RGC-5 cells for Brn3b (F), Brn3c (G) and γ Synuclein (H) is shown. Staining of nuclear DNA with DAPI is shown in blue. Blank indicates negative control where cells were processed similarly without addition of primary antibody. Panels show images captured using a fluorescence microscope at 40X magnification. Scale bar, 10 µm.CC BY · PubMed Central
Figure 2 Expression of neuronal markers in 661W cells. (A,C,E) Immunostaining of 661W and RGC-5 cells for NeuN (A), MAP2 (C) and beta-III tubulin (E). Blank indicates negative control where cells are processed similarly without addition of primary antibody. Scale bar, 10 µm. (B,D,F) 661W and RGC-5 cell lysates were resolved on SDS PAGE and blotted for the expression of NeuN (B), MAP-2 (D) and beta-III tubulin (F). Arrow heads indicate alternate isoforms of NeuN. Mouse retina was used as positive control.
Figure 2 Expression of neuronal markers in 661W cells. (A,C,E) Immunostaining of 661W and RGC-5 cells for NeuN (A), MAP2 (C) and beta-III tubulin (E). Blank indicates negative control where cells are processed similarly without addition of primary antibody. Scale bar, 10 µm. (B,D,F) 661W and RGC-5 cell lysates were resolved on SDS PAGE and blotted for the expression of NeuN (B), MAP-2 (D) and beta-III tubulin (F). Arrow heads indicate alternate isoforms of NeuN. Mouse retina was used as positive control.CC BY · PubMed Central
Figure 3 Expression of a cone-specific marker and nestin in 661W cells. (A) Semi quantitative PCR analysis for mRNA expression of cone-specific marker OPN1MW and neuronal precursor marker nestin. (B,C) Western blot analysis of 661W and RGC-5 cells showing the expression of OPN1MW and nestin, respectively. (D,E) Immunostaining of 661W and RGC-5 cells for OPN1MW and nestin respectively. Scale bar, 10 µm. (F) Expression analysis of GFAP, a glial cell specific marker by western blotting.
Figure 3 Expression of a cone-specific marker and nestin in 661W cells. (A) Semi quantitative PCR analysis for mRNA expression of cone-specific marker OPN1MW and neuronal precursor marker nestin. (B,C) Western blot analysis of 661W and RGC-5 cells showing the expression of OPN1MW and nestin, respectively. (D,E) Immunostaining of 661W and RGC-5 cells for OPN1MW and nestin respectively. Scale bar, 10 µm. (F) Expression analysis of GFAP, a glial cell specific marker by western blotting.CC BY · PubMed Central
Figure 4 Morphological analysis and differentiation of 661W and RGC-5 cells. 661W (A,C) and RGC-5 cells (B,D) were treated with 316 nM staurosporine (STSN) or vehicle (DMSO) for 24 hours, fixed and stained with specific antibody for acetylated tubulin (A,B). Staurosporine treatment induced neurite formation in 661W as well as RGC-5 cells. Scale bar: 10 µm. (C,D) Immunostaining of 661W and RGC-5 cells for RGC markers Brn3b, Brn3c and neuronal marker MAP-2 with antibodies. Scale bar, 10 µm. (E) Western blots showing the effect of differentiation with staurosporine on the level of Thy1, RBPMS, beta-III tubulin and NeuN proteins in 661W and RGC-5 cells. Numbers below the blots indicate quantitation of expression in differentiated cells relative to undifferentiated cells adjusted with actin loading control.
Figure 4 Morphological analysis and differentiation of 661W and RGC-5 cells. 661W (A,C) and RGC-5 cells (B,D) were treated with 316 nM staurosporine (STSN) or vehicle (DMSO) for 24 hours, fixed and stained with specific antibody for acetylated tubulin (A,B). Staurosporine treatment induced neurite formation in 661W as well as RGC-5 cells. Scale bar: 10 µm. (C,D) Immunostaining of 661W and RGC-5 cells for RGC markers Brn3b, Brn3c and neuronal marker MAP-2 with antibodies. Scale bar, 10 µm. (E) Western blots showing the effect of differentiation with staurosporine on the level of Thy1, RBPMS, beta-III tubulin and NeuN proteins in 661W and RGC-5 cells. Numbers below the blots indicate quantitation of expression in differentiated cells relative to undifferentiated cells adjusted with actin loading control.CC BY · PubMed Central
Figure 5 Effect of over-expression of OPTN and its mutants on the survival of 661W and NSC34 cells. (A,E) GFP tagged OPTN and its mutants were overexpressed by transfection in 661W and NSC34 cells grown on coverslips. After 32 hours of transfection, cells were stained for the detection of cell death. Panels show representative images of 661W (A) and NSC34 (E) cells expressing indicated proteins. Scale bar: 10 µm. (B,F) Quantitation of cell death induced by wild type OPTN and its mutants is shown in 661W and NSC34 cells, respectively. Data represent mean ± s.d. of percentage of GFP expressing cells showing Annexin V/7-AAD (Anx.V/7-AAD) staining after subtraction of cell death in non-expressing cells from three independent experiments done in duplicate. n = 6, ***p < 0.005. (D) Cell death induced by WT-OPTN and other glaucoma-associated mutants of OPTN quantitated using morphological criteria. Western blots show relative expression of OPTN and its mutants in 661W (C) and NSC34 cells (G). Actin was used as loading control.
Figure 5 Effect of over-expression of OPTN and its mutants on the survival of 661W and NSC34 cells. (A,E) GFP tagged OPTN and its mutants were overexpressed by transfection in 661W and NSC34 cells grown on coverslips. After 32 hours of transfection, cells were stained for the detection of cell death. Panels show representative images of 661W (A) and NSC34 (E) cells expressing indicated proteins. Scale bar: 10 µm. (B,F) Quantitation of cell death induced by wild type OPTN and its mutants is shown in 661W and NSC34 cells, respectively. Data represent mean ± s.d. of percentage of GFP expressing cells showing Annexin V/7-AAD (Anx.V/7-AAD) staining after subtraction of cell death in non-expressing cells from three independent experiments done in duplicate. n = 6, ***p < 0.005. (D) Cell death induced by WT-OPTN and other glaucoma-associated mutants of OPTN quantitated using morphological criteria. Western blots show relative expression of OPTN and its mutants in 661W (C) and NSC34 cells (G). Actin was used as loading control.CC BY · PubMed Central
Figure 6 Mechanism of M98K-OPTN and E50K-OPTN induced cell death in 661W cells. (A) Effect of various inhibitors and Atg5 knockdown on M98K-OPTN induced cell death. 661W cells transfected with GFP-M98K were treated with CQ (25 µM) or BX795 (1 µM) after 14 hours of transfection for 18 hours along with indicated controls and cell death was quantified based on Annexin V/7AAD positivity. 661W cells were cotransfected with GFP-M98K and control shRNA or Atg5shRNA and cell death was determined after 32 hours. (C) Effect of mutation of Ser177 to Ala in M98K-OPTN on induction of cell death in 661W cells. (E) Effect of antioxidant NAC and autophagy inducer rapamycin on E50K induced cell death. 661W cells were transfected with GFP-E50K. After 6 hours of transfection, cells were either treated with NAC (5 mM) for 26 hours or left untreated. GFP E50K transfected cells were treated with DMSO vehicle or rapamycin (1 µM) after 14 hours of transfection for 18 hours and cell death was quantified. (G) Effect of Tbk1 inhibitor on E50K-OPTN induced cell death. Treatment with BX795 (1 µM) was done as described for panel A. (A,C,E,G) Cell death data shown in bar diagrams represent mean ± s.d. of percentage of GFP expressing cells showing Annexin V/7-AAD (Anx. V/7-AAD) staining minus cell death in non-expressing cells from three independent experiments in duplicates. n = 6, ***p < 0.005 (B) Western blots showing expression of GFP-M98K upon CQ and BX795 treatment. Actin was used as loading control. (D) Western blot showing expression of the indicated mutants used for cell death experiment in C. (F) Western blots showing expression of GFP-E50K upon NAC and rapamycin treatment. (H) Western blots showing expression of GFP-M98K and GFP-E50K upon BX795 treatment. Actin was used as loading control. Numbers below the blots indicate quantitation of expression in treated cells relative to untreated cells adjusted with actin as loading control.
Figure 6 Mechanism of M98K-OPTN and E50K-OPTN induced cell death in 661W cells. (A) Effect of various inhibitors and Atg5 knockdown on M98K-OPTN induced cell death. 661W cells transfected with GFP-M98K were treated with CQ (25 µM) or BX795 (1 µM) after 14 hours of transfection for 18 hours along with indicated controls and cell death was quantified based on Annexin V/7AAD positivity. 661W cells were cotransfected with GFP-M98K and control shRNA or Atg5shRNA and cell death was determined after 32 hours. (C) Effect of mutation of Ser177 to Ala in M98K-OPTN on induction of cell death in 661W cells. (E) Effect of antioxidant NAC and autophagy inducer rapamycin on E50K induced cell death. 661W cells were transfected with GFP-E50K. After 6 hours of transfection, cells were either treated with NAC (5 mM) for 26 hours or left untreated. GFP E50K transfected cells were treated with DMSO vehicle or rapamycin (1 µM) after 14 hours of transfection for 18 hours and cell death was quantified. (G) Effect of Tbk1 inhibitor on E50K-OPTN induced cell death. Treatment with BX795 (1 µM) was done as described for panel A. (A,C,E,G) Cell death data shown in bar diagrams represent mean ± s.d. of percentage of GFP expressing cells showing Annexin V/7-AAD (Anx. V/7-AAD) staining minus cell death in non-expressing cells from three independent experiments in duplicates. n = 6, ***p < 0.005 (B) Western blots showing expression of GFP-M98K upon CQ and BX795 treatment. Actin was used as loading control. (D) Western blot showing expression of the indicated mutants used for cell death experiment in C. (F) Western blots showing expression of GFP-E50K upon NAC and rapamycin treatment. (H) Western blots showing expression of GFP-M98K and GFP-E50K upon BX795 treatment. Actin was used as loading control. Numbers below the blots indicate quantitation of expression in treated cells relative to untreated cells adjusted with actin as loading control.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 101

Metadata

Authors
Sayyad, Z., Sirohi, K., Radha, V., & Swarup, G.
Affiliations
Centre for Cellular and Molecular Biology (IN)
Corresponding author
  • Radha, Vegesna
  • Swarup, Ghanshyam
Venue
Scientific Reports
Published
2017-12-04
Volume
7
Issue
1
Pages
16855-16855
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2770372368
Cited by
96
References
62
Citations by year
2026: 5 · 2025: 14 · 2024: 6 · 2023: 14 · 2022: 11 · 2021: 13 · 2020: 16 · 2019: 8 · 2018: 9
FWCI
8.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Funders
Indian National Science Academy
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
Keywords
retinal ganglion cells, glaucoma, optineurin, amyotrophic lateral sclerosis, selective cell death, photoreceptors, RBPMS, Brn3b, CD90, gamma-synuclein, cell differentiation, cytoprotection
MeSH terms
Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Eye Proteins, Glaucoma, Microtubule-Associated Proteins, Nerve Tissue Proteins, Nuclear Proteins, Pyrimidines, Retinal Ganglion Cells, Thiophenes, Tubulin, Biomarkers, Mutagenesis, Site-Directed, Apoptosis, Cell Cycle Proteins, Thy-1 Antigens, Staurosporine, Membrane Transport Proteins, Transcription Factor Brn-3C, Mice, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 661W is a retinal ganglion precursor-like cell line in which glaucoma-associated optineurin mutants induce cell death selectively. https://app.cochat.ai/papers/10.1038/s41598-017-17241-0
The paper
Sayyad, Z., Sirohi, K., Radha, V., & Swarup, G. (2017). 661W is a retinal ganglion precursor-like cell line in which glaucoma-associated optineurin mutants induce cell death selectively. Scientific Reports. https://doi.org/10.1038/s41598-017-17241-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.